Panel Discussion: Advancing Sample Management & Pre-Analytic Workflows for Robust, Reproducible Clinical Outcomes

• What are the main challenges and hurdles considering clinical sample and biomarker strategies to reduce downstream risk? 
• What innovations in digital tools are facilitating end-to-end integrity and reproducibility?
• How are sponsors ensuring consistency in biospecimen handling when working across multiple CROs or laboratory partners?

Speakers:

Lorna McInroy

Director of Clinical Biomarkers

Moderna

Catherine Mela

Head Precision Medicine Operations

GlaxoSmithKline

Kristina McGuire

Executive Director & Head, Precision Medicine Laboratory Operations & Companion Diagnostics

Regeneron

Niall Martin

Biomarker Samples, Logistics & Operations Officer

Resolution Therapeutics